Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine

Carbohydrate Polymers

Volumn 149, Issue , 2016, Pages 28-39

  Zhao, Kai ^a,b   Sun, Yanwei ^b,c   Chen, Gang ^b   Rong, Guangyu ^b   Kang, Hong ^b   Jin, Zheng ^b   Wang, Xiaohua ^a,b  

^a UNIVERSITY OF JINAN   (China)

^b HEILONGJIANG UNIVERSITY   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Chitosan nanoparticles; Immune efficacy; Live Newcastle disease vaccine; Mucosal immune delivery system; N 2 hydroxypropyl trimethyl ammonium chloride; Newcastle disease

Indexed keywords

CHITIN; CHITOSAN; CHLORINE COMPOUNDS; EFFICIENCY; ENCAPSULATION; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; IMMUNE SYSTEM; MEDICAL APPLICATIONS; NANOPARTICLES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; VACCINES; VIRUSES; ZETA POTENTIAL;

CHITOSAN NANOPARTICLES; DELIVERY SYSTEMS; IMMUNE EFFICACY; NEWCASTLE DISEASE VACCINES; TRIMETHYL;

DISEASES;

CHITOSAN; CHITOSAN-N-2-HYDROXYPROPYL TRIMETHYL AMMONIUM CHLORIDE; DRUG CARRIER; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NANOPARTICLE; PRODRUG; VIRUS VACCINE;

ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CHEMISTRY; CHICKEN; CYTOLOGY; IMMUNIZATION; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; NEWCASTLE DISEASE VIRUS; PARTICLE SIZE; PHYSIOLOGY; SAFETY; VIRUS LOAD;

ANIMALS; CHICKENS; CHITOSAN; DRUG CARRIERS; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LYMPHOCYTES; NANOPARTICLES; NEWCASTLE DISEASE VIRUS; PARTICLE SIZE; PRODRUGS; SAFETY; VIRAL LOAD; VIRAL VACCINES;

EID: 84966716340     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2016.04.085     Document Type: Article

References (59)

1. G. Ana, E.G. Manuela, R. Marcia, E.S. Vítor, F.M. João, and M.N. Nuno Development of new chitosan/carrageenan nanoparticles for drug delivery applications Journal of Biomedical Materials 25 2009 1265 1272
2. J.B. Arous, S. Deville, J.K. Pal, S. Baksi, F. Bertrand, and L. Dupuis Reduction of Newcastle disease vaccine dose using a novel adjuvant for cellular immune response in poultry Procedia in Vaccinology 7 2013 28 33
3. N.S. Barakat, and A.S. Almurshedi Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation Journal of Pharmacy and Pharmacology 63 2 2011 169 178
4. S. Boyoglu, K. Vig, S. Pillai, V. Rangari, V.A. Dennis, F. Khazi, and et al. Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus Nanomedicine 5 4 2009 463 472
5. E.A. Corbanie, J.P. Remon, K.V. Reeth, W.J.M. Landman, J.H.H. Van Eck, and C. Vervaet Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry Vaccine 25 2007 8306 8317
6. C.X. Dai, H. Kang, W.Q. Yang, J.Y. Sun, C.L. Liu, G.G. Cheng, and et al. O-2′-Hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine Carbohydrate Polymers 130 2015 180 189
7. A. Des Rieux, V. Fievez, M. Garinot, Y.J. Schneider, and V. Préat Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach Journal of Controlled Release 116 2006 1 27
8. D.L. Ewert, B.O. Barger, and C.S. Eidson Local antibody response in chickens: analysis of antibody synthesis to Newcastle disease virus by solid-phase radioimmunoassay and immunofluorescence with classs-pecific antibody for chicken immunoglobulins Infection and Immunity 24 1979 269 275
9. Y. Fan, J.J. Moon, D. Irvine, and A. Editor Nanoparticle drug delivery systems designed to improve cancer vaccines and immunotherapy Vaccines 3 3 2015 662 685
10. K. Ganar, M. Das, S. Sinha, and S. Kumar Newcastle disease virus: current status and our understanding Virus Research 184 2014 71 81
11. V. Gerdts, G. Mutwiri, J. Richards, S. van Drunen Littel-van den Hurk, and A.A. Potter Carrier molecules for use in veterinary vaccines Vaccine 31 2013 596 602
12. R. Greenwood, and K. Kendall Electroacoustic studies of moderately concentrated colloidal suspensions Journal of the European Ceramic Society 19 4 1999 479 488
13. 2 Journal of the European Ceramic Society 32 1 2012 235 244
14. M. Herr, H. Bostedt, and K. Failing IgG and IgM levels in dairy cows during the periparturient period Theriogenology 75 2011 377 385
15. S.L. Hu, H.L. Ma, Y.T. Wu, W.B. Liu, X.Q. Wang, Y.L. Liu, and et al. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics Vaccine 27 2009 904 910
16. K. Huyge, K. Van Reeth, T. De Beer, W.J.M. Landman, J.H.H. Van Eck, J.P. Remon, and et al. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry European Journal of Pharmaceutics and Biopharmaceutics 80 2012 649 656
17. L. Illum, I. Jabbal-Gill, M. Hinchcliffe, A.N. Fisher, and S.S. Davis Chitosan as a novel nasal delivery system for vaccines Advanced Drug Delivery Reviews. 51 2001 81 96
18. Z. Jin, W. Li, H.W. Cao, X. Zhang, G. Chen, H. Wu, and et al. Antimicrobial activity and cytotoxicity of N-2-HACC and characterization of nanoparticles with N-2-HACC and CMC as a vaccine carrier Chemical Engineering Journal 221 2013 331 341
19. D.R. Kapczynski, C.L. Afonso, and P.J. Miller Immune responses of poultry to Newcastle disease virus Developmental and Comparative Immunology 41 2013 447 453
20. S. Koppad, G.D. Raj, V.P. Gopinath, J.J. Kirubaharan, A. Thangavelu, and V. Thiagarajan Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens Research in Veterinary Science 91 2011 384 390
21. A. Li, L.L. Qin, W.R. Wang, R.R. Zhu, Y.C. Yu, H. Liu, and et al. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of antimelanoma immune response Biomaterials 32 2 2011 469 477
22. H.J. Liu, P. Zhang, P.P. Wu, S.L. Chen, G.H. Mu, X.J. Duan, and et al. Phylogenetic characterization and virulence of two Newcastle disease viruses isolated from wild birds in China Infect. Genetics Selection Evolution 20 2013 215 224
23. S.W. Liu, H.Y. Chen, D.J. Cao, and J.L. Lu Effect on chicken lymphocytes by Newcastle disease virus Chinese Journal of Animal Poult Infection Diseases 20 3 1998 140 142
24. Y. Liu, L. y. Wang, Y. Zhang, W.F. Zhang, X.M. Chen, T.Y. Yang, and et al. Uniform-sized water-in-oil vaccine formulations enhance immune response against Newcastle disease and avian influenza in chickens International Immunopharmacology 23 2014 603 608
25. X. Ma, Z.H. Guo, Z.Q. Shen, J.L. Wang, Y.L. Hu, and D.Y. Wang The immune enhancement of propolis adjuvant on inactivated porcine parvovirus vaccine in guinea pig Cellular Immunology 270 2011 13 18
26. O.C. Marino, and R.P. Hanson Cellular and humoral response of in vivo-bursectomized chickens to experimental challenge with velogenic disease virus Avian Diseases 31 1987 293 301
27. J. Mast, C. Nanbru, M. Decaesstecker, B. Lambrecht, B. Couvreur, G. Meulemans, and et al. Vaccination of chicken embryos with escape mutants of La Sota Newcastle disease virus induces a protective immune response Vaccine 24 2006 1756 1765
28. P.J. Miller, C.L. Afonso, J.E. Attrache, K.M. Dorsey, S.C. Courtney, Z.J. Guo, and et al. Effects of Newcastle disease virus vaccine antibodies on the shedding and transmission of challenge viruses Developmental and Comparative Immunology 41 2013 505 513
29. P.J. Miller, D.J. King, C.L. Afonso, and D.L. Suarez Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge Vaccine 25 2007 7238 7246
30. J.J. Moon, H. Suh, M.E. Polhemus, C.F. Ockenhouse, A. Yadava, and D.J. Irvine Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a plasmodium vivax malaria vaccine Plos One 7 2 2012 e31472
31. S. Natesan, Y. Sameena, V.M.V. Enoch, S.P. Mosae, and D. Premnath On the accessibility of surface-bound drugs on magnetic nanoparticles: encapsulation of drugs loaded on modified dextran-coated superparamagnetic iron oxide by β-cyclodextrin Colloids and Surfaces B: Biointerfaces 141 2016 423 428
32. H. Niels, J.V. Rolf, M. Imke, P.H.J.F. De Jong, E. Mastrobattista, H.L. Glansbeek, and et al. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine Journal of Controlled Release 140 2009 126 133
33. R. Parker, S. Deville, L. Dupuis, F. Bertrand, and J. Aucouturier Adjuvant formulation for veterinary vaccines: montanide Gel safety profile Procedia in Vaccinology 1 2009 140 147
34. J. Pleidrup, T.S. Dalgaard, L.R. Norup, A. Permin, T.W. Schoub, K. Skovgaard, and et al. Ascaridia galli infection influences the development of both humoral and cell-mediated immunity after Newcastle Disease vaccination in chickens Vaccine 32 2014 383 392
35. F. Rauw, Y. Gardin, V. Palya, S. Anbari, M. Gonze, S. Lemaire, and et al. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine Veterinary Immunology and Immunopathology 134 2010 249 258
36. F. Rauw, Y. Gardin, V. Palya, S. Van Borm, M. Gonze, S. Lemaire, and et al. Humoral, cell-mediated and mucosal immunity induced by oculo-nasalvaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines Vaccine 27 2009 3631 3642
37. D.L. Reynolds, and A.D. Maraqa Protective immunity against Newcastle Disease: the role of antibodies specific to Newcastle disease virus polypeptides Avian Diseases 44 2000 138 144
38. D.L. Reynolds, and A.D. Maraqa Protective immunity against newcastle disease: the role of cell-mediated immunity Avian Diseases 44 1 2000 145 154
39. P.H. Russell, and G. Koch Local antibody forming cell responses to the Hitchner B1 and Ulster strains of Newcastle disease virus Veterinary Immunology and Immunopathology 37 1993 165 180
40. B. Savita, G. Bhakta, S. Mitra, and A. Maitra PDNA loaded calcium phosphate nanoparticles: highly efficient non-viral vector for gene delivery International Journal of Pharmaceutics 288 2005 157 168
41. R. Scherlie, S. Buske, K. Young, B. Weber, T. Rades, and S. Hook In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations Vaccine 31 2013 4812 4819
42. A. Srinivasan, A. Rastogi, V. Ayyavoo, and S. Srivastava Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 33 3 2014 186 191
43. Y.W. Sun, Y. Zhang, C. Shi, W. Li, G. Chen, X.H. Wang, and et al. Newcastle disease virus vaccine encapsulated in biodegradable nanoparticles for mucosal delivery of a human vaccine Human Vaccines & Immunotherapeutics 10 8 2014 2503 2506
44. I. Tretyakova, I.S. Lukashevich, P. Glass, E. Wang, S. Weaver, and P. Pushko Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine Vaccine 31 7 2013 1019 1025
45. L.P. Tseng, C.J. Chiou, C.C. Chen, M.C. Deng, T.W. Chung, Y.Y. Huang, and et al. Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens Veterinary Immunology and Immunopathology 131 2009 285 289
46. R. Tsunekuni, H. Hikono, and T. Saito Evaluation of avian Paramyxovirus serotypes 2-10 as vaccine vectors in chickens previously immunized against Newcastle disease virus Veterinary Immunology and Immunopathology 160 2014 184 191
47. M.I. Ugwoke, R.U. Agu, N. Verbeke, and R. Kinget Nasal mucoadhesive drug delivery, Background, applications: trends and future perspectives Advanced Drug Delivery Reviews 57 2005 1640 1665
48. M. Wang, R.L. Yang, L.F. Zhang, X.Y. Meng, C.Z. Fei, K.Y. Zhang, and et al. Sulfated glucan can improve the immune efficacy of Newcastle disease vaccine in chicken International Journal of Biological Macromolecules 70 2014 193 198
49. 2@LDH nanoparticles as an adjuvant Biomaterials 35 2014 466 478
50. Z.S. Wen, Y.L. Xu, X.T. Zou, and Z.R. Xu Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice Marine Drugs 9 6 2011 1038 1055
51. S.D. Xiang, S. Anja, M. Gabriela, D. Cassandra, A. Vasso, L.M. Patricia, and et al. Pathogen recognition and development of particulate vaccines: does size matter? Methods 40 1 2006 1 9
52. W. Yu, and H. Xie A Review on nanofluids: preparation, stability mechanisms and applications Journal of Nanomaterials 2012 2012 1 17
53. Y. Yu, D.Q. Wang, S. Abula, Y.L. Hu, X.J. Zhao, Y. Huang, and et al. The immunological adjuvant activity of gypenosides liposome against Newcastle disease vaccine International Journal of Biological Macromolecules 60 2013 116 121
54. X.F. Zhang, X.W. Zhang, and Q. Yang Effect of compound mucosal immune adjuvant on mucosal and systemic immune responses in chicken orally vaccinated with attenuated Newcastle-disease vaccine Vaccine 25 2007 3254 3262
55. K. Zhao, G. Chen, X.M. Shi, T.T. Gao, W. Li, Y. Zhao, and et al. Preparation and efficacy of a live Newcastle disease virus vaccine encapsulated in chitosan nanoparticles Plos One 7 12 2012 e53314
56. X.J. Zhao, Y.P. Fan, D.Y. Wang, Y.L. Hu, L.W. Guo, S.L. Ruan, and et al. Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine Vaccine 29 2011 9611 9617
57. K. Zhao, W. Li, T.T. Huang, X.M. Luo, G. Chen, Y. Zhang, and et al. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles Plos One 8 12 2013 e82648
58. L. Zhao, A. Seth, N. Wibowo, C.X. Zhao, N. Mitter, C.Z. Yu, and et al. Nanoparticle vaccines Vaccine 32 2014 327 337
59. F.J. Zhao, Y.M. Wu, X.H. Zhang, J. Yu, W.M. Gu, S.Q. Liu, and et al. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2 Human Vaccines 7 10 2011 1083 1089